Primary record
4-Methoxy-6-[[(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-5-methyl- 3-pyridinemethanol sodium salt
- 库存
- 6,800 克
- 纯度
- 99.4 %
- CAS
- 92340-57-3
化合物标识与属性
- CAS
- 92340-57-3
- PubChem CID
- 119560
- SMILES
- CC1=C(C(=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)OC)CO)OC
- Canonical SMILES
- COc1ccc2nc(S(=O)Cc3ncc(CO)c(OC)c3C)[nH]c2c1
名称与同义词
- Hydroxyomeprazole
- 5-HYDROXY OMEPRAZOLE
- 5-HYDROXYOMEPRAZOLE
- 5'-Hydroxyomeprazole
- 5-Hydroxymethylomeprazole
- 92340-57-3
- 5-Hydroxyesomeprazole
- 5 -Hydroxyomeprazole
- AC1Q6YJT
- RefChem:536251
- UNII-JOT1NT1B70
- 5'-Hydroxyomeprazole, R-
- (S)-5-Hydroxy Omeprazole
- 5/'-Hydroxyomeprazole, R-
- Hydroxyomeprazole Sodium Salt
- DTXSID50919234
- AC1L3P18
- orb1692700
- SCHEMBL3058978
- CHEMBL3527071
- SCHEMBL29817590
- 5-Hydroxy Omeprazole-(Pyridyl)-d3
- 5-Hydroxyomeprazole sodium sa lt
- C17H19N3O4S
- CHEBI:63840
- 5-Hydroxy Omeprazole Sodium Salt
- CMZHQFXXAAIBKE-UHFFFAOYSA-N
- KST-1A9218
- AR-1A5882
- C17-H19-N3-O4-S
- CID119560
- AKOS005146284
- AKOS037645535
- 1-Bromo-4-chloro-2,5-dimethylbenzene
- AS-6126
- CID:119560
- FH24077
- 5-Hydroxyomeprazole, analytical standard
- BB061000
- PD057530
- SID:381756636
- HY-126857
- J513.684I
- CS-0107818
- FT-0651053
- NS00015362
- 5-Methoxy-2-(((4-methoxy-3-methyl-5-hydroxymethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
- H36141
- [4-methoxy-6-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-5-methylpyridin-3-yl]methanol
- 340H573
- C049963
- 5-Hydroxy Omeprazole (~5per cent Triethylamine as stabilizer)
- Q27132844
- 5-Hydroxy Omeprazole (~5% Triethylamine as stabilizer)
- (4-methoxy-6-{[(6-methoxy-1h-benzimidazol-2-yl)sulfinyl]methyl}-5-methylpyridin-3-yl)methanol
- 4-Methoxy-6-(((5-methoxy-1H-benzimidazol-2-yl)sulfinyl)methyl)-5-methyl-3-pyridinemethanol
- 196489-27-7
- 3-Pyridinemethanol, 4-methoxy-6-(((5-methoxy-1H-benzimidazol-2-yl)sulfinyl)methyl)-5-methyl-
- 4-Methoxy-6-[[(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-5-methyl-3-pyridinemethanol
- 1189882-58-3
- 981-24-8
- [4-methoxy-6-[(6-methoxy-1H-benzimidazol-2-yl)sulfinylmethyl]-5-methyl-3-pyridyl]methanol
- {4-Methoxy-6-[(6-methoxy-1H-benzimidazole-2-sulfinyl)methyl]-5-methylpyridin-3-yl}methanol
- P450 (CYP) metabolite|||Phase I metabolite of omeprazole|||CYP2C19 reference metabolite
- (4-methoxy-6-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-5-methylpyridin-3-yl)methanol
- (4-methoxy-6-{[(5-methoxy-1H-1,3-benzodiazol-2-yl)sulfinyl]methyl}-5-methylpyridin-3-yl)methanol
- (4-methoxy-6-{[(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl}-5-methylpyridin-3-yl)methanol
- (S)-(4-Methoxy-6-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-5-methylpyridin-3-yl)methanol
- {4-Methoxy-6-[(6-methoxy-1H-1,3-benzimidazole-2-sulfinyl)methyl]-5-methylpyridin-3-yl}methanol
- {4-methoxy-6-[(6-methoxy-1H-1,3-benzodiazole-2-sulfinyl)methyl]-5-methylpyridin-3-yl}methanol
- 1215629-45-0
- 196489-26-6
- 2-[[(5-Methoxy-1H-benzimidazole-2-yl)sulfinyl]methyl]-3-methyl-4-methoxypyridine-5-methanol
- 4-Methoxy-6-[[(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-5-methyl- 3-pyridinemethanol sodium salt
- 4-Methoxy-6-[[(S)-(6-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-5-methyl-3-pyridinemethanol